GlassScriptPhysician profile
Justin P Kubeck
NPI 1063613339
$309,140.80
in general payments reported to CMS, 2019-2025
14 companies · $15K in 2025
The $15K reported for 2025 was more than what 75% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $18K · 2021: $35K · 2022: $11K · 2023: $130K · 2024: $80K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $125K · Consulting Fee: $81K · Travel and Lodging: $14K · Food and Beverage: $3,700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $125,000.00 |
| Consulting Fee | $81,350.00 |
| Travel and Lodging | $13,959.57 |
| Food and Beverage | $3,700.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $222,106.56 | 2023-2025 | Mariner Mis Tlif Retractor, Mariner Mis, Mariner Mis Tlif Retractor |
| Nuvasive, INC. | $46,641.86 | 2019-2022 | |
| Seaspine Orthopedics Corporation | $38,035.24 | 2021-2022 | |
| Alphatec Spine, INC | $508.98 | 2024-2025 | Other - Miscellaneous, Identiti, Lif |
| Si-Bone, INC. | $399.48 | 2019-2021 | |
| Intrinsic Therapeutics | $359.39 | 2025 | Barricaid Acd (Annular Closure Device) |
| Globus Medical, INC. | $354.52 | 2024-2025 | Rise, Simplify Cervical Artificial Disc, Monument |
| Providence Medical Technology, INC. | $253.68 | 2022-2025 | |
| Trackx Technology, INC. | $179.48 | 2025 | |
| Carlsmed, INC. | $150.35 | 2024 | Aprevo |
| Vb Spine LLC | $98.11 | 2025 | Everest Spinal System |
| Abbott Laboratories | $35.14 | 2024 | Proclaim |
| Misonix INC | $18.01 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$3,668,350.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Kubeck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.